Literature DB >> 11913914

Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia.

Peter A Bampton1, Jayne J Sandford, Graeme P Young.   

Abstract

OBJECTIVES: To determine whether applying National Health and Medical Research Council (NHMRC) guidelines for colorectal cancer prevention would reduce the number of follow-up colonoscopies.
DESIGN: A prospective audit of colonoscopic surveillance decisions before and after the intervention.
SETTING: The endoscopy suite at a metropolitan tertiary hospital three months before and after January 2000. INTERVENTION: Dissemination of NHMRC guidelines, and supervision of application of the guidelines by a nurse coordinator.
SUBJECTS: We compared colonoscopic surveillance decisions before and after the intervention in two groups of 100 consecutive patients after polypectomy and in two groups of 50 consecutive patients with a family history of colorectal cancer after a normal colonoscopy. MAIN OUTCOME MEASURES: Change in concordance of decisions with NHMRC guidelines; and effect on number of follow-up colonoscopies.
RESULTS: After the intervention, the proportion of postpolypectomy surveillance decisions matching the guidelines increased from 37% to 96% (P < 0.05). The mean time to repeat colonoscopy after polypectomy increased from 2.7 to 3.5 years (P < 0.005) (ie, a 23% reduction in the number of postpolypectomy surveillance colonoscopies performed per year). Likewise, the proportion of family-history surveillance decisions matching the guidelines increased from 63% to 96%. Adhering to the guidelines resulted in a 17% reduction in colonoscopies performed on the basis of a family history of colorectal cancer.
CONCLUSIONS: Supervised application of evidence-based guidelines to a colorectal cancer surveillance program significantly reduces the number of surveillance colonoscopies performed.

Entities:  

Mesh:

Year:  2002        PMID: 11913914     DOI: 10.5694/j.1326-5377.2002.tb04344.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Sessile Serrated Polyps with Synchronous Conventional Adenomas Increase Risk of Future Advanced Neoplasia.

Authors:  Erin Symonds; Shahzaib Anwar; Graeme Young; Rosie Meng; Michelle Coats; Kalindra Simpson; Peter Bampton; Robert Fraser; Charles Cock
Journal:  Dig Dis Sci       Date:  2019-01-09       Impact factor: 3.199

2.  Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.

Authors:  P A Bampton; J J Sandford; S R Cole; A Smith; J Morcom; B Cadd; G P Young
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia.

Authors:  Michael P Pignone; Kathy L Flitcroft; Kirsten Howard; Lyndal J Trevena; Glenn P Salkeld; D James B St John
Journal:  Med J Aust       Date:  2011-02-21       Impact factor: 7.738

4.  Improving surveillance for Barrett's oesophagus.

Authors:  Peter A Bampton; Anne Schloithe; Jeff Bull; Robert J Fraser; Rob T A Padbury; David I Watson
Journal:  BMJ       Date:  2006-06-03

5.  Evidence based medicine: an overview.

Authors:  Sameeh M Al-Almaie; Nadira A Al-Baghli
Journal:  J Family Community Med       Date:  2003-05

6.  Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: a randomized controlled trial.

Authors:  Mariko Carey; Rob Sanson-Fisher; Finlay Macrae; David Hill; Catherine D'Este; Christine Paul; Christopher Doran
Journal:  BMC Cancer       Date:  2012-02-08       Impact factor: 4.430

7.  Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study.

Authors:  Else-Mariëtte B van Heijningen; Iris Lansdorp-Vogelaar; Ewout W Steyerberg; S Lucas Goede; Evelien Dekker; Wilco Lesterhuis; Frank ter Borg; Juda Vecht; Pieter Spoelstra; Leopold Engels; Clemens J M Bolwerk; Robin Timmer; Jan H Kleibeuker; Jan J Koornstra; Harry J de Koning; Ernst J Kuipers; Marjolein van Ballegooijen
Journal:  Gut       Date:  2015-01-13       Impact factor: 23.059

8.  Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data.

Authors:  David B Preen; Iris Lansdorp-Vogelaar; Hooi C Ee; Cameron Platell; Dayna R Cenin; Lakkhina Troeung; Max Bulsara; Peter O'Leary
Journal:  Front Public Health       Date:  2017-09-08

9.  Improving adherence to colorectal cancer surveillance guidelines: results of a randomised controlled trial.

Authors:  Mariko Carey; Robert Sanson-Fisher; Finlay Macrae; Emilie Cameron; David Hill; Catherine D'Este; Christopher Doran
Journal:  BMC Cancer       Date:  2017-02-06       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.